Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Vitzthum

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2024
Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trialBrianna Lau, Yufan F Wu, Sunan Cui, et al.
Oral Oncology|November 21, 2022
Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapyHannah C Liu, Casey W Williamson, Jingjing Zou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2023
Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic AgentsBrianna C Lau, Yufan F Wu, Hyunsoo J No, et al.
Clinical Lung Cancer|December 1, 2023
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II TrialCaressa Hui, Eleanor Brown, Samantha Wong, et al.
Annals of Surgery|December 16, 2024
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?M Usman Ahmad, Christopher S Javadi, Julia D Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2023
BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation TherapyLucas K Vitzthum, Murat Surucu, Michael F Gensheimer, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
JAMA Oncology|September 14, 2023
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled TrialMichael F Gensheimer, Harriet Gee, Hiroki Shirato, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2024
Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative RiskRyan T Morse, Tyler J Nelson, Hannah C Liu, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 28, 2024
Chest wall pain after single-fraction thoracic stereotactic ablative Radiotherapy: Dosimetric analysis from the iSABR trialBrianna Lau, Yufan F Wu, Sunan Cui, et al.
Oral Oncology|November 21, 2022
Quantitative prediction of aspiration risk in head and neck cancer patients treated with radiation therapyHannah C Liu, Casey W Williamson, Jingjing Zou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2023
Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic AgentsBrianna C Lau, Yufan F Wu, Hyunsoo J No, et al.
Clinical Lung Cancer|December 1, 2023
Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II TrialCaressa Hui, Eleanor Brown, Samantha Wong, et al.
Annals of Surgery|December 16, 2024
Biochemical, Radiographic, or Pathologic Response to Neoadjuvant Chemotherapy in Resected Pancreatic Cancer: Which is Best?M Usman Ahmad, Christopher S Javadi, Julia D Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 26, 2023
BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation TherapyLucas K Vitzthum, Murat Surucu, Michael F Gensheimer, et al.
Cancer|October 5, 2020
Predictive classifier for intensive treatment of head and neck cancerKaveh Zakeri, Federico Rotolo, Benjamin Lacas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
Nomogram to Predict the Benefit of Intensive Treatment for Locoregionally Advanced Head and Neck CancerLoren K Mell, Hanjie Shen, Phuc Felix Nguyen-Tân, et al.
JAMA Oncology|September 14, 2023
Individualized Stereotactic Ablative Radiotherapy for Lung Tumors: The iSABR Phase 2 Nonrandomized Controlled TrialMichael F Gensheimer, Harriet Gee, Hiroki Shirato, et al.
International Journal of Radiation Oncology, Biology, Physics|September 22, 2024
Redefining Candidates for Deintensification in Locoregionally Advanced P16+ Oropharyngeal Cancer Based on Relative RiskRyan T Morse, Tyler J Nelson, Hannah C Liu, et al.
Pageof 7